The Ozempic Paradox: Why Americans Can't Let Go of Stigma The popularity of GLP 1 drugs like Ozempic, Wegovy, and Mounjaro has sent a clear message to the pharmaceutical industry: these medications are in high demand.
Yet despite their success, Americans continue to harbor deep seated negative feelings towards those who use them. The so called "Ozempic stigma" persists, raising more questions than answers.
One might assume that as more people take GLP 1 drugs for weight loss or diabetes management, societal attitudes would gradually shift from disdain to acceptance.